InvaGen Pharmaceuticals, Inc.: Drug Recall
Recall #D-0220-2024 · 11/17/2023
Class I: Dangerous
Recall Details
- Recall Number
- D-0220-2024
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- InvaGen Pharmaceuticals, Inc.
- Status
- Completed
- Date Initiated
- 11/17/2023
- Location
- Central Islip, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1240 boxes
Reason for Recall
Defective Container: powder may leak out of the pouch
Product Description
Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
Distribution Pattern
Nationwide within the United States
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.